lupus erythematosus, systemic

Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey
Marlene Plüß, Gamal Chehab, Peter Korsten

Annals of the Rheumatic Diseases Jul 2020, annrheumdis-2020-217967; DOI: 10.1136/annrheumdis-2020-217967
Response to: ‘Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey’ by Plüß et al
Alexis Mathian, Zahir Amoura

Annals of the Rheumatic Diseases Jul 2020, annrheumdis-2020-218069; DOI: 10.1136/annrheumdis-2020-218069
Response to: ‘Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis’ by Györfi et al
Milena Gianfrancesco, Kimme L Hyrich, Jinoos Yazdany, Pedro M Machado, Philip C Robinson

Annals of the Rheumatic Diseases Jun 2020, annrheumdis-2020-218328; DOI: 10.1136/annrheumdis-2020-218328
Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China ‘hot spot’ versus in US ‘hot spot’: similarities and differences
Jun Zhao, Rongrong Pang, Jian Wu, Yanju Guo, Yang Yang, Libo Zhang, Xinyi Xia

Annals of the Rheumatic Diseases Jun 2020, annrheumdis-2020-218183; DOI: 10.1136/annrheumdis-2020-218183
Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments
Zoé Gendebien, Christian von Frenckell, Clio Ribbens, Béatrice André, Marie Thys, Marjorie Gangolf, Laurence Seidel, Michel G Malaise, Olivier Malaise

Annals of the Rheumatic Diseases Jun 2020, annrheumdis-2020-218244; DOI: 10.1136/annrheumdis-2020-218244
Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: ‘Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?’ by Xie et al
Carmen Magdalena Gamboa-Alonso, Gabriel Figueroa-Parra, Dionicio Angel Galarza-Delgado

Annals of the Rheumatic Diseases Jun 2020, annrheumdis-2020-217633; DOI: 10.1136/annrheumdis-2020-217633
Mounting data indicate that antimalarials do not prevent mild or severe COVID-19 in rheumatic patients. Response to: ‘The role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients’ by Favalli et al
Vasco C Romão, Ana Rita Cruz-Machado, João Eurico Fonseca

Annals of the Rheumatic Diseases Jun 2020, annrheumdis-2020-218175; DOI: 10.1136/annrheumdis-2020-218175
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Milena Gianfrancesco, Kimme L Hyrich, Sarah Al-Adely, Loreto Carmona, Maria I Danila, Laure Gossec, Zara Izadi, Lindsay Jacobsohn, Patricia Katz, Saskia Lawson-Tovey, Elsa F Mateus, Stephanie Rush, Gabriela Schmajuk, Julia Simard, Anja Strangfeld, Laura Trupin, Katherine D Wysham, Suleman Bhana, Wendy Costello, Rebecca Grainger, Jonathan S Hausmann, Jean W Liew, Emily Sirotich, Paul Sufka, Zachary S Wallace, Jinoos Yazdany, Pedro M Machado, Philip C Robinson

Annals of the Rheumatic Diseases Jul 2020, 79 (7) 859-866; DOI: 10.1136/annrheumdis-2020-217871
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies
Carlos Sanchez-Piedra, Cesar Diaz-Torne, Javier Manero, José M Pego-Reigosa, Íñigo Rúa-Figueroa, Miguel A Gonzalez-Gay, Juan Gomez-Reino, Jose M Alvaro-Gracia

Annals of the Rheumatic Diseases Jul 2020, 79 (7) 988-990; DOI: 10.1136/annrheumdis-2020-217948
Response to: ‘Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak’ by Holubar et al
Alexis Mathian, Zahir Amoura

Annals of the Rheumatic Diseases Jun 2020, annrheumdis-2020-217988; DOI: 10.1136/annrheumdis-2020-217988

Main menu

lupus erythematosus, systemic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

lupus erythematosus, systemic

Pages